文献速递消化道肿瘤与早癌

活化ATF6诱导肠道菌群失调和先天免疫反应促进结直肠肿瘤发生

Activated ATF6 Induces Intestinal Dysbiosis and Innate Immune Response to Promote Colorectal Tumorigenesis.
PubMed 文献 · Gastroenterology · 2018-07-29

研究分析癌症基因组图谱中541例结直肠癌患者及德国83例结直肠癌队列,并在肠道上皮细胞特异性表达活性ATF6的转基因小鼠中验证。发现ATF6表达升高与无病生存期缩短相关,小鼠在12周龄发生结肠腺瘤,菌群失调和细菌穿透内黏液层先于肿瘤形成,抗生素减少肿瘤发生率,无菌饲养完全阻止肿瘤发生,肿瘤起始需MyD88/TRIF依赖的STAT3活化。

要点

  • ATF6表达升高与结直肠癌患者无病生存期缩短相关。
  • 肠道上皮细胞持续活化ATF6的小鼠发生肠道菌群失调并自发形成结肠腺瘤。
  • 肿瘤发生依赖菌群及MyD88/TRIF介导的STAT3活化,无菌条件可完全预防。

核心结论

  • 在结直肠癌患者中,ATF6与无病生存时间缩短相关。
  • 在nATF6IEC小鼠研究中,结肠内持续的肠道ATF6活化促进菌群失调和菌群依赖性肿瘤发生。

研究设计与样本

  • 分析癌症基因组图谱数据库中541例结直肠癌患者的遗传变异和未折叠蛋白反应基因异常表达水平。
  • 在德国83例结直肠癌患者队列中验证上述发现。
  • 构建肠道上皮细胞特异性表达活性ATF6的2个等位基因(纯合)、1个等位基因(杂合)及对照(nATF6IECfl/fl)小鼠,饲养于无特定病原体或无菌条件下。
  • 将纯合nATF6IEC小鼠或对照小鼠的盲肠菌群移植入纯合nATF6IEC小鼠或对照小鼠。
  • 将nATF6IEC小鼠与Myd88/Trif敲除小鼠杂交,并对小鼠肠道组织进行组织学、免疫组化、免疫印迹、未折叠蛋白反应和炎症基因表达谱、基于芯片的比较基因组杂交及16S核糖体RNA基因测序分析。

主要发现

  • ATF6表达升高与结直肠癌患者无病生存时间缩短相关。
  • 纯合nATF6IEC小鼠在12周龄发生自发性结肠腺瘤。
  • 与对照相比,纯合nATF6IEC小鼠盲肠菌群谱改变、肠上皮细胞增殖增加及黏液屏障丢失,这些均先于肿瘤形成。
  • 上述小鼠细菌穿透内黏液层增加并激活信号转导及转录激活因子3,但在肿瘤前或肿瘤阶段未观察到炎症。
  • 给纯合nATF6IEC小鼠使用抗生素大幅降低肿瘤发生率,无菌饲养完全预防肿瘤发生。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Activating transcription factor 6 (ATF6) regulates endoplasmic reticulum stress. We studied whether ATF6 contributes to the development of colorectal cancer (CRC) using tissue from patients and transgenic mice. METHODS: We analyzed data from 541 patients with CRC in The Cancer Genome Atlas database for genetic variants and aberrant expression levels of unfolded protein response genes. Findings were validated in a cohort of 83 patients with CRC in Germany. We generated mice with intestinal epithelial cell-specific expression of the active form of Atf6 (nATF6IEC) from 2 alleles (homozygous), mice with expression of nATF6IEC from 1 allele (heterozygous), and nATF6IECfl/fl mice (controls). All nATF6IEC mice were housed under either specific-pathogen-free or germ-free conditions. Cecal microbiota from homozygous nATF6IEC mice or control mice was transferred into homozygous nATF6IEC mice or control mice. nATF6IEC mice were crossed with mice with disruptions in the myeloid differentiation primary response gene 88 and toll-like receptor adaptor molecule 1 gene (Myd88/Trif-knockout mice). Intestinal tissues were collected from mice and analyzed by histology, immunohistochemistry, immunoblots, gene expression profiling of unfolded protein response and inflammatory genes, array-based comparative genome hybridization, and 16S ribosomal RNA gene sequencing. RESULTS: Increased expression of ATF6 was associated with reduced disease-free survival times of patients with CRC. Homozygous nATF6IEC mice developed spontaneous colon adenomas at 12 weeks of age. Compared with controls, homozygous nATF6IEC mice had changes in the profile of their cecal microbiota, increased proliferation of intestinal epithelial cells, and loss of the mucus barrier-all preceding tumor formation. These mice had increased penetration of bacteria into the inner mucus layer and activation of signal transducer and activator of transcription 3, yet inflammation was not observed at the pretumor or tumor stages. Administration of antibiotics to homozygous nATF6IEC mice greatly reduced tumor incidence, and germ-free housing completely prevented tumorigenesis. Analysis of nATF6IEC MyD88/TRIF-knockout mice showed that tumor initiation and growth required MyD88/TRIF-dependent activation of signal transducer and activator of transcription 3. Transplantation of cecal microbiota from nATF6IEC mice and control mice, collected before tumor formation, caused tumor formation in ex-germ-free nATF6IEC mice. CONCLUSIONS: In patients with CRC, ATF6 was associated with reduced time of disease-free survival. In studies of nATF6IEC mice, we found sustained intestinal activation of ATF6 in the colon to promote dysbiosis and microbiota-dependent tumorigenesis.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Coleman OI, Lobner EM, Bierwirth S, et al. Activated ATF6 Induces Intestinal Dysbiosis and Innate Immune Response to Promote Colorectal Tumorigenesis. Gastroenterology. 2018. PMID: 30063920. doi:10.1053/j.gastro.2018.07.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。